ASCI
You are here: Skip Navigation LinksHome > HCP > Cancer immunotherapy

Patient website

Website dedicated to help patients, their family and friends about the cancer immunotherapeutic approach in an easy-to-understand format.

Visit Patient website

MAGRIT trial

Website providing information about the now recruiting Non-Small Cell Lung Cancer phase III clinical study

www.ascitrials.com

Cancer immunotherapy is a potential new treatment for cancer

This section describes the potential of cancer immunotherapy as a new treatment to fight tumors. Cancer immunotherapy aims at stimulating and enhancing the natural immune response to tumor cells.

This can be achieved either by:

  • Stimulating the whole immune system, or
  • passively administering antibodies (passive immunotherapy), or
  • actively inducing an immune response against specific antigens found on tumor cells (active immunotherapy)

ASCI (or Antigen-Specific Cancer Immunotherapeutics) is an immunotherapy approach that aims at educating the patients’ own immune system to fight the tumor.

New user?

Welcome to www.gsk-asci.com

If this is your first time at this site, please click here to register.

Register now

Why register?

For legal reasons, this page is intended solely for healthcare professionals. This is why we ask you to register.

Last update: 27-May-2009
ASCIs are investigational compounds